drugset / Trial / NCT01598740
Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine the effects of CLP, with and without spironolactone, on serum, urine, and fecal contents in heart failure patients with chronic kidney disease.
Timeline
- Start
- 2012-06
- Primary completion
- 2012-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CLP | Unknown | — | Oral |
| Subject | Spironolactone | Small molecule | — | Oral |